Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0751651 (
mitochondrial disease
)
1,844
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ischemia and anoxia-induced mitochondrial impairment may be a key factor leading to heart injury during myocardial infarction (MI). Calpain 1 and 2 are involved in the MI-induced mitochondria injury.
G protein-coupled receptor 35
(
GPR35
) could be triggered by hypoxia. Whether or not
GPR35
regulates calpain 1/2 in the pathogenesis of MI is still unclear. In this study, we determined that MI increases
GPR35
expression in myocardial tissue. Suppression of
GPR35
protects heart from MI injury in mice through reduction of reactive oxygen species activity and mitochondria-dependent apoptosis. Further studies show that
GPR35
regulates calpain 1/2. Suppression of
GPR35
reduces the expression and activity of calpain 1/2, and alleviates calpain 1/2-associated mitochondrial injury to preserve cardiac function. Based on these data, we conclude that a functional inhibition of
GPR35
downregulates calpain 1/2 and contributes to maintenance of cardiac function under pathologic conditions with
mitochondrial disorder
. In conclusion, our study showed that the identified regulation by
GPR35
of calpain 1/2 has important implications for the pathogenesis of MI. Targeting the action of
GPR35
and calpain 1/2 in mitochondria presents a potential therapeutic intervention for MI.
...
PMID:Inhibition of GPR35 Preserves Mitochondrial Function After Myocardial Infarction by Targeting Calpain 1/2. 3219 56